SCHEMBL4285254

SCHEMBL4285254

COC(=O)c1ccc(Cc2ccc(OC)cc2)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.53
SAE1 Q9UBE0 1/20 0.53
UBA2 Q9UBT2 1/20 0.53
PARP1 P09874 1/20 0.51
DYRK1A Q13627 1/20 0.49
CYP1A2 P05177 2/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C9 P11712 2/20 0.49
ALDH1A1 P00352 2/20 0.49
POLB P06746 1/20 0.49
HPGD P15428 1/20 0.49
CYP2C19 P33261 1/20 0.49
ATM Q13315 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDM4E B2RXH2 1/20 0.46
ASPH Q12797 1/20 0.46
RIOX2 Q8IUF8 1/20 0.46
KDM8 Q8N371 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11635981 0.87 ALDH1A1 (0.50) SAE1UBA2CYP1A2CYP3A4CYP2C9
SCHEMBL11630275 0.86 MAPK1 (0.54) MAPK1PARP1L3MBTL1KDM4ELTA4H
SCHEMBL11632984 0.86 MAPK1 (0.54) MAPK1PARP1DYRK1AALDH1A1POLB
SCHEMBL11630361 0.86 P4HTM (0.55) MAPK1SAE1UBA2CYP1A2CYP3A4
SCHEMBL753810 0.85 MAPK1 (0.53) MAPK1PARP1ALDH1A1POLBHPGD
SCHEMBL11635977 0.85 MAPK1 (0.53) MAPK1PARP1DYRK1ACYP1A2CYP3A4
SCHEMBL1545257 0.82 MAPK1 (0.65) MAPK1DYRK1ACYP1A2CYP3A4CYP2C9
SCHEMBL31296544 0.82 MAPK1 (0.65) MAPK1DYRK1ACYP1A2CYP3A4CYP2C9
SCHEMBL11630925 0.81 TSHR (0.56) MAPK1SAE1UBA2PARP1CYP1A2
SCHEMBL7883731 0.80 MAPK1 (0.62) MAPK1PARP1DYRK1ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 MAPK1 427/4885SAE1 3842/4885UBA2 3223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.